Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma. - Naghavi, Arash O.; Bryant, J. M.; Kim, Youngchul; Weygand, Joseph; Redler, Gage; Sim, Austin J.; Miller, Justin; Coucoules, Kaitlyn; Michael, Lauren Taylor; Gloria, Warren E.; Yang, George; Rosenberg, Stephen A.; et al. (BMC Cancer, 2024)